Drug Channels

APRIL 2, 2024

For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. and 12.3.4.

Pharmacy 65

Pharmacy Drugs 65

Drug Channels

OCTOBER 10, 2023

The notable new material in this 2023-24 edition includes: New data about commercial pricing and reimbursement for provider-administered biosimilars appears in Section 3.2.2. and Section 6.4.3. A new Section 6.2.2. A new Section 6.3.2. Group purchasing organizations for small pharmacies (Section 2.2.5.)

Pharmacy 40

Pharmacy Licensing Licensing Containment 40

Drug Discovery World

SEPTEMBER 28, 2022

You can read this entire book as a holistic approach or jump straight to the section that is most relevant to your needs, from an elaboration on how bioelectronic assays allow scientists to precisely and continuously monitor cultured cells without labels or dyes, to commentary on what’s driving lab analysis by DDW Editor Reece Armstrong. .

Drugs 52

Drugs Antibody Scientist Development 52

Drug Discovery World

JANUARY 16, 2024

Dr Masaru Kanekiyo On Tuesday 6 February at 11.30am, the speaker will be Masaru Kanekiyo, DVM, PhD, Investigator and Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), NIH. See the full programme and register your interest in this event.

Vaccination 64

Vaccination Vaccine Allergies Protein 64

Drug Discovery World

DECEMBER 8, 2022

The results were presented at the International Diabetes Federation (IDF) World Diabetes Congress 2022. . The post Positive Phase III trial data for SGLT2 inhibitor in type 2 diabetes appeared first on Drug Discovery World (DDW).

Trials 52

Trials Insulin Clinical Trials Clinical Trials 52

Drug Channels

OCTOBER 5, 2021

The notable new material in this 2021-22 edition includes three new sections: Section 4.2.5. Section 4.4. Section 7.4.4. We consider McKesson’s exit from Europe in Section 9.4.3.) (We consider McKesson’s exit from Europe in Section 9.4.3.) Section 6.1.5. WHAT’S GOING ON.

Licensing 62

Licensing Licensing Containment Pharmacy 62

Drug Discovery World

NOVEMBER 16, 2023

We were very encouraged by the findings,” said Evgeny Izumchenko, Assistant Professor of Medicine at UChicago in the section of haematology and oncology. The post AI and transcriptomics identify dual targets for ageing and cancer appeared first on Drug Discovery World (DDW).

Medicine 80

Medicine Engineer Research Gene 80

Drug Discovery World

NOVEMBER 30, 2023

The initial approvals of these products included postmarketing requirements (PMRs) under Section 505(o) of the Federal Food, Drug, and Cosmetic Act (FDCA) to conduct 15-year long term follow-up observational safety studies to assess the long-term safety and the risk of secondary malignancies occurring after treatment.

Cosmetics 64

Cosmetics Clinical Trials Clinical Trials Gene Therapy 64

Drug Discovery World

AUGUST 31, 2023

Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World The post FDA expands Reblozyl approval to first-line use appeared first on Drug Discovery World (DDW). Today’s approval represents an important advancement for patients with lower-risk MDS.” In the COMMANDS trial, results showed 58.5%

Trials 52

Trials Drugs 52

Drug Channels

MARCH 15, 2022

The report has been thoroughly updated with the latest data and includes loads of new material and new sections. In some small way, I try to make the world a better and smarter place. Many sections and chapters have been expanded and/or reorganized to better cover the latest industry developments. WHAT’S GOING ON.

Pharmacy 85

Pharmacy Drugs Marketing Licensing 85

Drug Channels

OCTOBER 11, 2022

The notable new material in this 2022-23 edition includes three new sections: Section 3.4.1. Section 6.1.6. Section 6.1.6. We also update sections that were introduced in recent editions, such as our estimates of wholesalers' profits from provider-administered biosimilar drugs.

Licensing 56

Licensing Licensing Containment Drugs 56

Drug Discovery World

DECEMBER 13, 2023

On Tuesday 6 February at 11.30am, attendees will hear on the topic ‘Structural vaccinology for influenza’ from Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC) at the US National Institute of Allergy and Infectious Diseases (NIAID). Register now to show your interest.

Allergies 52

Allergies Engineer Drugs Development 52

Drug Discovery World

DECEMBER 5, 2023

” The post FDA approves second indication for Lilly’s BTK inhibitor Jaypirca appeared first on Drug Discovery World (DDW). . ” The post FDA approves second indication for Lilly’s BTK inhibitor Jaypirca appeared first on Drug Discovery World (DDW).

FDA Approval 52

FDA Approval Trials Drugs Marketing 52

Drug Discovery World

FEBRUARY 2, 2024

Tuesday 6 Feb 11am Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC), NIAID: ‘Structural vaccinology for influenza’. Tuesday 6 Feb 11am Masaru Kanekiyo, Chief of Molecular Immunoengineering Section of the Vaccine Research Center (VRC), NIAID: ‘Structural vaccinology for influenza’.

Engineer 59

Engineer Drugs Sales Antibody 59

Drug Discovery World

DECEMBER 19, 2023

appeared first on Drug Discovery World (DDW). The post SLAS2024 Ignite Theater: Will you be there?

Vaccination 64

Vaccination Vaccine Genome Genomics 64

Camargo

NOVEMBER 15, 2021

FDA Guidance Addresses Real-World Evidence Data Standards. The 21 st Century Cures Act generated a good deal of excitement and interest when it added a section called “ Utilizing Real World Evidence ” to the Food, Drug, and Cosmetic Act (Section 505F).

Development 187

Development Manufacturing Production Packaging 187

Drug Discovery World

AUGUST 16, 2023

The antibody, called Ab-IPL-IL-17, targets a specific section of signalling proteins IL-17A and IL-17F which play a central role in sustaining inflammation during onset and progression of autoimmune diseases.

Antibody 52

Antibody Immune Response Protein Research 52

World of DTC Marketing

APRIL 8, 2022

When I launched Sarafem, we had a section where visitors could post stories about their experiences in dealing with PMDD. The post About those online metrics appeared first on World of DTC Marketing.com. Advertisers should not care about protecting a media company or social nnetwork’sproprietary information or algorithms.

Branding 199

Branding Marketing Drugs Production 199

Drug Discovery World

DECEMBER 11, 2023

It has been remarkable to be part of this groundbreaking programme,” said Stephan Grupp, Section Chief of the Cellular Therapy and Transplant Section and Director of the Kelly Center for Cancer Immunotherapy at the Children’s Hospital of Philadelphia. No patients experienced graft failure or graft rejection. “It

Gene Therapy 52

Gene Therapy FDA Approval Gene Gene Editing 52

Drug Discovery World

DECEMBER 18, 2023

Reduced sensitivity to HIV Scientists in the HIV-Specific Immunity Section of NIAID’s Laboratory of Immunoregulation and colleagues found that both HIV vaccine recipients and LTNPs/ECs generated large numbers of CD8+ T cells that recognised HIV.

Vaccination 59

Vaccination Vaccine Allergies Clinical Trials 59

Drug Discovery World

MARCH 31, 2023

The benefits of Fast Track Designation include a ‘rolling review’ of completed sections of the New Drug Application (NDA), more frequent interaction with the FDA to expedite the review process, and potential eligibility for accelerated approval and priority review. “The

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

Drug Discovery World

JANUARY 20, 2023

Clinical trials have led our news section this week, with positive results announced from several Phase I and II studies. The post This week in drug discovery (16-20 January) appeared first on Drug Discovery World (DDW). News round-up for 19-20 January by DDW Digital Content Editor Diana Spencer.

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

FDA Law Blog

MAY 8, 2023

FDORA added section 515C, “Predetermined Change Control Plans for Devices” to the Federal Food, Drug, and Cosmetic (FD&C) Act. Components of a PCCP The draft guidance describes the sections that should be included as part of a PCCP and the specific information that should be included under each section.

Manufacturing 98

Manufacturing Marketing Regulation Cosmetics 98

The Pharma Data

MARCH 9, 2021

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s Investor website at [link]. Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. About Eli Lilly and Company.

Medicine 52

Medicine 52

Pfizer

FEBRUARY 1, 2023

Closing the Cancer Care Gap: World Cancer Day and Beyond kimkevin Wed, 02/01/2023 - 10:44 Closing the Cancer Care Gap: World Cancer Day and Beyond Friday, February 03, 2023 - 10:00am Share Every two seconds, someone in the world is diagnosed with cancer. 2 For instance, Black men in the U.S. References Sung, H., Siegel, R.,

Clinical Trials 98

Clinical Trials Clinical Trials Medicine Trials 98

Pharmaceutical Technology

JUNE 5, 2023

Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health. A ransomware group later claimed responsibility for the incident, which was one of several high-profile cybersecurity breaches in India over the past three years. Cybersecurity is necessary for biosecurity.”

Compliance 276

Compliance Regulation Pharmacy Genome 276

Roots Analysis

MARCH 6, 2023

Digital twins are virtual representations of real-world objects. In the following sections, we explore the top three benefits offered by these technologies. This means that healthcare providers can see and respond to real-time changes / real world evidence and abnormalities. What is a Digital Twin?

52

52

The Pharma Data

APRIL 11, 2023

Key presentations on Bayer research to be presented at AACR 2023 are listed below: Oral presentation: BAY 2965501: A highly selective DGKzeta inhibitor for cancer immuno-therapy with first-in-class potential Abstract ND04, Session DDT001 – New Drugs on the Horizon: Part 1 Sunday, April 16, 2:05 PM – 2:20 PM (EDT), Tangerine Ballroom 2 (WF2) – (..)

Research 40

Research Clinical Trials Clinical Trials Trials 40

World of DTC Marketing

SEPTEMBER 7, 2022

According to JAMA , “in a cross-sectional study, between May 1, 2016, and May 31, 2021, there were 207 cancer drug approvals in oncology and malignant hematology. The post The current pharma business model is unsustainable appeared first on World of DTC Marketing.com. The biggest battle arena by far is oncology. ” The U.S.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

pharmaphorum

NOVEMBER 3, 2022

The non-governmental organisations – which include Oxfam, Medecins sans Frontieres, Global Justice Now and Health Poverty Action, amongst others – are worried about sections of the draft deal dealing with intellectual property. ” The post NGOs claim UK-India free trade deal will raise medicine prices appeared first on.

Medicine 85

Medicine Pharma Companies Sales Drugs 85

Drug Discovery World

FEBRUARY 8, 2024

Andrea O’Hara, PhD, Strategic Technical Specialist, Azenta Life Sciences led the presentation and was joined by Elizabeth Louie, PhD, Supervisor, Technical Applications, Xiangying Mao, PhD, Team Lead, Bioinformatics, and Crystal Richardson, PhD, Business Partnership Manager – all Azenta Life Sciences – for the questions section.

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

Drug Discovery World

JULY 4, 2023

Our understanding of the aetio-pathogenesis is improving, but our treatment options remain limited,” said Professor Jimmy Limdi, Consultant Gastroenterologist/Head of IBD Section at Northern Care Alliance NHS Foundation Trust and Professor of Gastroenterology at University of Manchester. After treatment with mirikizumab, 42.9%

Drugs 52

Drugs Clinical Trials Clinical Trials Trials 52

pharmaphorum

NOVEMBER 23, 2020

German digital health company smartpatient is adding a new section of its MyTherapy app providing information on wet age-related macular degeneration (AMD), a leading cause of blindness.

Marketing 98

Marketing Sales Doctors Doctor 98

The Pharma Data

MAY 5, 2021

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly ‘s Investor website at [link]. Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. About Eli Lilly and Company?

Medicine 52

Medicine 52

pharmaphorum

JULY 12, 2022

With growing numbers of people around the world living with long-term conditions, the pharmaceutical industry has a golden opportunity to use its expertise to truly enhance lives. Effective self-management also places less burden on healthcare systems, as demonstrated in a 2018 cross-sectional analysis of electronic health records.

Production 110

Production Clinical Trials Clinical Trials Trials 110

Drug Discovery World

NOVEMBER 2, 2022

An estimated 241 million cases of malaria occurred worldwide in 2020, according to the World Health Organization , resulting in an estimated 627,000 deaths, mostly in children in sub-Saharan Africa. . The post Monoclonal antibody could transform malaria prevention appeared first on Drug Discovery World (DDW).

Antibody 52

Antibody Allergies Trials Medicine 52

World of DTC Marketing

JANUARY 6, 2021

I just finished reading the latest edition of MedAd News and besides being really dip pointed with the content I was extremely put back by the section on agency people speculating on the changes brought on by the pandemic. appeared first on World of DTC Marketing.com. First let’s me discuss the elephant in the room, telehealth.

Pharma Production 180

Pharma Production Production Marketing Drugs 180